The college stated that triglyceride-lowering therapies could be considered to lower ASCVD risk in patients following the use of LDL-C lowering therapy. The organization also noted additional stresses and lifestyle choices that could reduce the risk of ASCVD, including heart-healthy diets, regular physical activity, not using tobacco, minimal alcohol consumption and maintaining a healthy weight.
The recommendations were published July 28 in the Journal of the American College of Cardiology.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
